300 related articles for article (PubMed ID: 24020826)
1. In vivo confocal microscopy of conjunctiva in preservative-free timolol 0.1% gel formulation therapy for glaucoma.
Frezzotti P; Fogagnolo P; Haka G; Motolese I; Iester M; Bagaglia SA; Mittica P; Menicacci C; Rossetti L; Motolese E
Acta Ophthalmol; 2014 Mar; 92(2):e133-40. PubMed ID: 24020826
[TBL] [Abstract][Full Text] [Related]
2. An in vivo confocal microscopy and impression cytology analysis of preserved and unpreserved levobunolol-induced conjunctival changes.
Ciancaglini M; Carpineto P; Agnifili L; Nubile M; Fasanella V; Lanzini M; Calienno R; Mastropasqua L
Eur J Ophthalmol; 2008; 18(3):400-7. PubMed ID: 18465723
[TBL] [Abstract][Full Text] [Related]
3. Long term safety and tolerability of Tafluprost 0.0015% vs Timolol 0.1% preservative-free in ocular hypertensive and in primary open-angle glaucoma patients: a cross sectional study.
Rolle T; Spinetta R; Nuzzi R
BMC Ophthalmol; 2017 Aug; 17(1):136. PubMed ID: 28768500
[TBL] [Abstract][Full Text] [Related]
4. An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology.
Martone G; Frezzotti P; Tosi GM; Traversi C; Mittica V; Malandrini A; Pichierri P; Balestrazzi A; Motolese PA; Motolese I; Motolese E
Am J Ophthalmol; 2009 Apr; 147(4):725-735.e1. PubMed ID: 19181302
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers.
Manni G; Centofanti M; Oddone F; Parravano M; Bucci MG
Am J Ophthalmol; 2005 Jan; 139(1):72-7. PubMed ID: 15652830
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications.
Lazreg S; Merad Z; Nouri MT; Garout R; Derdour A; Ghroud N; Kherroubi R; Meziane M; Belkacem S; Ouhadj O; Baudouin C; Tiar M
J Fr Ophtalmol; 2018 Dec; 41(10):945-954. PubMed ID: 30477719
[TBL] [Abstract][Full Text] [Related]
7. Meibomian Gland Features and Conjunctival Goblet Cell Density in Glaucomatous Patients Controlled With Prostaglandin/Timolol Fixed Combinations: A Case Control, Cross-sectional Study.
Agnifili L; Mastropasqua R; Fasanella V; Brescia L; Scatena B; Oddone F; Mastropasqua L
J Glaucoma; 2018 Apr; 27(4):364-370. PubMed ID: 29401160
[TBL] [Abstract][Full Text] [Related]
8. Short-term effect of latanoprost and timolol eye drops on tear fluid and the ocular surface in patients with primary open-angle glaucoma and ocular hypertension.
Thygesen J; Aaen K; Theodorsen F; Kessing SV; Prause JU
Acta Ophthalmol Scand; 2000 Feb; 78(1):37-44. PubMed ID: 10726786
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety evaluation of benzalkonium chloride preserved eye-drops compared with alternatively preserved and preservative-free eye-drops in the treatment of glaucoma: a systematic review and meta-analysis.
Hedengran A; Steensberg AT; Virgili G; Azuara-Blanco A; Kolko M
Br J Ophthalmol; 2020 Nov; 104(11):1512-1518. PubMed ID: 32051133
[TBL] [Abstract][Full Text] [Related]
10. Effect of timolol with and without preservative on the basal tear turnover in glaucoma.
Kuppens EV; de Jong CA; Stolwijk TR; de Keizer RJ; van Best JA
Br J Ophthalmol; 1995 Apr; 79(4):339-42. PubMed ID: 7742279
[TBL] [Abstract][Full Text] [Related]
11. Ocular surface changes in glaucomatous patients treated with and without preservatives beta-blockers.
Iester M; Telani S; Frezzotti P; Motolese I; Figus M; Fogagnolo P; Perdicchi A;
J Ocul Pharmacol Ther; 2014 Aug; 30(6):476-81. PubMed ID: 24787056
[TBL] [Abstract][Full Text] [Related]
12. Adverse effects of topical antiglaucomatous medications on the conjunctiva and the lachrymal (Brit. Engl) response.
Nuzzi R; Finazzo C; Cerruti A
Int Ophthalmol; 1998; 22(1):31-5. PubMed ID: 10090446
[TBL] [Abstract][Full Text] [Related]
13. Tafluprost/Timolol: A Review in Open-Angle Glaucoma or Ocular Hypertension.
Hoy SM
Drugs; 2015 Oct; 75(15):1807-13. PubMed ID: 26431840
[TBL] [Abstract][Full Text] [Related]
14. Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication.
Uusitalo H; Chen E; Pfeiffer N; Brignole-Baudouin F; Kaarniranta K; Leino M; Puska P; Palmgren E; Hamacher T; Hofmann G; Petzold G; Richter U; Riedel T; Winter M; Ropo A
Acta Ophthalmol; 2010 May; 88(3):329-36. PubMed ID: 20546237
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and safety of preserved versus preservative-free beta-blockers in patients with glaucoma or ocular hypertension: a systematic review.
Skov AG; Rives AS; Freiberg J; Virgili G; Azuara-Blanco A; Kolko M
Acta Ophthalmol; 2022 May; 100(3):253-261. PubMed ID: 34128326
[TBL] [Abstract][Full Text] [Related]
16. Effects of SofZia-preserved travoprost and benzalkonium chloride-preserved latanoprost on the ocular surface -- a multicentre randomized single-masked study.
Aihara M; Oshima H; Araie M;
Acta Ophthalmol; 2013 Feb; 91(1):e7-e14. PubMed ID: 23241328
[TBL] [Abstract][Full Text] [Related]
17. Chronic topical eye preservative-free beta-blocker therapy effect on the ocular surface in glaucomatous patients.
Campagna P; Macri A; Rolando M; Calabria G
Acta Ophthalmol Scand Suppl; 1997; (224):53. PubMed ID: 9589739
[No Abstract] [Full Text] [Related]
18. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
Sonty S; Mundorf TK; Stewart JA; Stewart WC
Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
[TBL] [Abstract][Full Text] [Related]
19. [Structural and immunohistochemical changes of conjunctiva induced by topical glaucoma medication].
Nenciu A; Stefan C; Ardelean C
Oftalmologia; 2004; 48(1):35-42. PubMed ID: 15279417
[TBL] [Abstract][Full Text] [Related]
20. Effects of antiglaucoma drugs on ocular surface.
Yalvaç IS; Gedikoğlu G; Karagöz Y; Akgün U; Nurözler A; Koç F; Kasim R; Duman S
Acta Ophthalmol Scand; 1995 Jun; 73(3):246-8. PubMed ID: 7493237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
